Trial Profile
A Single-center, Placebo-controlled, Double-blind Study to Evaluate the Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2018
Price :
$35
*
At a glance
- Drugs Relamorelin (Primary)
- Indications Constipation; Diabetic gastroparesis; Gastrointestinal disorders
- Focus Pharmacodynamics
- Sponsors Rhythm; Rhythm Pharmaceuticals
- 24 May 2016 Results presented at the Digestive Disease Week 2016
- 13 Oct 2015 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov.
- 17 Jun 2015 New trial record